Recombinant Anti-CD3 x Anti-PSCA Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CD3 antibody are both extended with the scFv fragment from an anti-PSCA antibody. This BsAb can retarget T cells to tumor cells. It is designed for the research of Prostate cancer therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY